Phase 3 Readout~month

Phase 3 Topline: PH Weighted Chemical Exchange Saturation Transfer Based Surgical Resections of Glioblastoma

June 1, 2030

Company: Black Diamond Therapeutics, Inc. (BDTX)
Indication: Glioblastoma

Other upcoming events for BDTX

Patent ExpiryPatent/Exclusivity Expiry: FIBRICOR

Phase 2 ReadoutPhase 2 Readout: silevertinib

Phase 3 ReadoutPhase 3 Topline: A Phase 3 Study of Dinutuximab Added to Intensive Multimodal Therapy for Children With Newly Diagnos

Patent ExpiryPatent/Exclusivity Expiry: IWILFIN

Patent ExpiryPatent/Exclusivity Expiry: SEGLENTIS

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start Free Full Calendar

Phase 3 Topline: PH Weighted Chemical Exchange Saturation Transfer Based Surgical Resections of Glioblastoma — BDTX Phase 3 Readout | BioSniper